Many vaccine trials use age de-escalation with the goal of safeguarding the interests of younger, more vulnerable populations. After a vaccine's safety and efficacy are established in adult populations, progressively younger ...
Feb 21, 2023
0
20
Interactive risk communication formats can be more effective than conventional text-based formats in overcoming vaccine hesitancy and building public trust. These are the findings of a study conducted by researchers at Charité-Universitätsmedizin ...
Feb 16, 2023
0
41
It has been more than 100 years since the first and only tuberculosis (TB) vaccine—the Bacillus Calmette–Guérin (BCG) vaccine—was used for the first time medically in 1921. With an estimated 1.6 million people dying ...
Feb 15, 2023
1
25
The global epidemic innovations fund said Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against COVID.
Jan 17, 2023
0
5
As a surge in cases of respiratory syncytial virus, or RSV, continues pushing hospitals to capacity across the U.S., researchers at Georgia State's Institute for Biomedical Sciences are working to develop vaccines and other ...
Jan 6, 2023
0
8
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
40
Former federal MP Dr. Kerryn Phelps has talked this week about the medical problems she and her wife had after their COVID-19 vaccinations around 18 months ago.
Dec 22, 2022
0
9
A new report from Indiana University sociologist Jessica Calarco and Ph.D. candidate Elizabeth Anderson sheds light on why the rate of COVID-19 vaccination among U.S. children is far lower than the rate of vaccination among ...
Dec 13, 2022
0
19
Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.
Nov 21, 2022
0
26
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
Nov 3, 2022
0
23
